BENIGN UTERINE CONDITIONS THERAPY SYSTEMS MARKET

108 Pages | 12 Exhibits | 2016 Analysis | Forecasts Through 2020 Product Family: Market Reports




OVERVIEW:
This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the benign uterine condition (BUC) therapy systems market, including global endometrial ablation systems, MR-guided focused ultrasound systems, uterine artery embolization systems, and hysteroscopes/fibroid removal systems.

BENIGN UTERINE CONDITION MARKET HIGHLIGHTS

  • Fewer than 15% of the 100m women worldwide with dysfunctional uterine bleeding (DUB) receive treatment. Of the 1.8m hysterectomies performed annually worldwide, DUB treatment accounts for half.
  • The combined global market for BUC therapy products totalled nearly $1.3bn in 2015, and is expected to grow at a CAGR of 4.7% through 2020.
  • The hysteroscopes segment is expected to account for the most dollar sales (with $788m in 2015), and the MRgFUS segment is expected to experience the most growth (10.8% from 2015-2020)
  • Drivers of the MRgFUS market will include the technique's approved use in women wishing to preserve fertility, in addition to safety concerns regarding morcellation, which may drive usage of alternative therapies such as MRgFUS.
KEY QUESTIONS ANSWERED
  • What are the key drivers and limiters to the BUC therapy systems market?
  • Which competitors are leading the market, and which are developing novel technologies?
  • How are technologiecal advancements impacting market growth?
  • Which areas of the BUC therapy systems market are experiencing dynamic growth?
  • How are competition and pricing pressures affecting the market shares of leading competitors?


TABLE OF CONTENTS:
EXECUTIVE SUMMARY
 
i. Global endometrial ablation products 
ii. Magnetic resonance-guided focused ultrasound systems 
iii. Uterine artery embolization systems 
iv. Hysteroscopes and fibroid removal systems 
v. Combined market analysis 
vi. Methodology 

Exhibit ES-1: Benign uterine conditions therapy systems, market forecast, 2015-20 

1. BENIGN UTERINE CONDITION TREATMENT OVERVIEW
 
1.1 Dilation and curettage 
	1.1.1 Procedure volumes forecast 
1.2 Hysterectomy 
	1.2.2 Procedure volumes forecast 
1.3 Hysteroscopy 
	1.3.1 Endometrial ablation 
	1.3.2 Procedure volumes forecast 
1.4 Myomectomy 
	1.4.1 Procedure volumes forecast 
1.5 Bibliography
 
Exhibit 1-1: Menorrhagia treatments and side effects 
Exhibit 1-2: Dilation and curettage, global procedure volumes forecast, by region, 2015-20
Exhibit 1-3: Hysterectomy, global procedure volumes forecast, by region, 2015-20
Exhibit 1-4: Hysteroscopy, global procedure volumes forecast, by region, 2015-20
Exhibit 1-5: Myomectomy, global procedure volumes forecast, by region, 2015-20

2. GLOBAL ENDOMETRIAL ABLATION PRODUCTS MARKET
 
2.1 Reimbursement 
2.2 Products and Competitors 
	2.2.1 Boston Scientific 
	2.2.2 CooperSurgical/The Cooper Companies 
	2.2.3 Hologic 
	2.2.4 Idoman 
	2.2.5 Minerva Surgical 
	2.2.6 Veldana Medical 
2.3 Clinical Trials Comparing Non-Resectoscopic Devices 
2.4 Recent Market Developments 
2.5 Emerging Products and Competitors 
	2.5.1 AEGEA Medical 
	2.5.2 Channel Medsystems 
	2.5.3 Minitouch/MicroCube 
	2.5.4 Halt Medical 
2.6 Market Analysis 
2.7 Competitive Analysis 
2.8 Bibliography
 
Exhibit 2-1: Global endometrial ablation devices, market forecast, by region, 2015-20
Exhibit 2-2: Global endometrial ablation devices market, sales and share by supplier, 2015 and 2020 

3. MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND SYSTEMS MARKET
 
3.1 Products and Competitors 
	3.1.1 InSightec 
	3.1.2 Philips Healthcare/Royal Philips 
3.2 Reimbursement 
3.3 Market Analysis 
3.4 Bibliography 

4. UTERINE EMBOLIZATION SYSTEMS MARKET
 
4.1 Products and Competitors 
	4.1.1 Biocompatibles/BTG International 
	4.1.2 Boston Scientific 
	4.1.3 Cook Medical/Cook Group 
	4.1.4 Merit Medical Systems 
	4.1.5 Terumo 
	4.1.6 Comparison of embolization devices 
4.2 Embolization versus other techniques for treating uterine fibroids 
4.3 Market analysis 
4.4 Competitive analysis 
4.5 Bibliography
 
Exhibit 4-1: Global uterine artery embolization systems, market forecast, by region, 2015-20
Exhibit 4-2: Global uterine embolization systems market, sales and share by supplier, 2015 and 2020 

5. HYSTEROSCOPES AND FIBROID REMOVAL SYSTEMS MARKET
 
5.1 Regulatory Issues 
5.2 Products and Competitors 
	5.2.1 Boston Scientific 
	5.2.2 Ethicon/Johnson & Johnson 
	5.2.3 Hologic 
	5.2.4 Olympus 
	5.2.5 Karl Storz Endoscopy 
	5.2.6 LiNA Medical 
	5.2.7 Medtronic 
	5.2.8 Stryker 
	5.2.9 Richard Wolf Medical Instruments 
5.3 Uterine Manipulators 
5.4 Fluid Management Systems 
5.5 Market Analysis 
5.6 Competitive Analysis 
5.7 Bibliography 

Exhibit 5-1: Global hysteroscopes and related products, market forecast, by region, 2015-20
Exhibit 5-2: Global hysteroscopes and related products market, sales and share by supplier, 2015 and 2020 

APPENDIX A: COMPANY LISTING



COMPANIES COVERED:

  1. AEGEA Medical, Inc.
  2. Alfresa Pharma Corporation
  3. Biocompatibles LTD/BTG International PLC
  4. Boston Scientific Corporation
  5. Channel Medsystems, Inc.
  6. ConMed Corporation
  7. Cook Medical/Cook Group, Inc.
  8. CooperSurgical, Inc./The Cooper Companies
  9. CR Bard, Inc.
  10. Ethicon, Inc./Johnson & Johnson
  11. Halt Medical, Inc.
  12. Hologic, Inc.
  13. Idoman Teoranta LTD
  14. InSightec LTD
  15. Karl Storz GmbH & Co. KG
  16. LiNA Medical ApS
  17. MedGyn, Inc.
  18. Medtronic PLC
  19. Merit Medical Systems, Inc.
  20. Minerva Surgical, Inc.
  21. Minitouch/Microcube LLC
  22. Olympus Corporation
  23. Philips Healthcare/Koninklijke Philips NV
  24. Richard Wolf Medical Instruments Corporation
  25. Rudolf Medical GmbH & Co. KG
  26. Scholly Fiberoptic GmbH
  27. Smith & Nephew PLC
  28. Stryker Corporation
  29. Terumo Medical Corporation/Terumo Corporation
  30. Veldana Medical SA
  31. Xion Medical GmbH
Contact Us

Need help finding medtech research? Let us help you!